ElevateBio, LLC
Company, not a person
Files as director, 10% owner at Allovir, Inc. (KLRS)
ElevateBio, LLC is a company, not a person, and it has filed 1 insider report with the SEC since August 2022, as director and 10% owner at Allovir, Inc. (KLRS). The latest filing, on August 1, 2022, reports grant or award at Allovir, Inc. (KLRS).
- Filings
- 1
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where ElevateBio, LLC is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director, 10% owner | 16,674,766 | $1.43 | Aug 1, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
Other insiders at the same companies
- Amy O'Leary VandekopKLRS
- Laurie KeatingKLRS
- Liisa Ann BaykoKLRS
- Morana Jovan-EmbiricosKLRS
- Napoleone FerraraKLRS
- David HallalKLRS
- Srinivas AkkarajuKLRS
- Michael DybbsKLRS
- Anthony P AdamisKLRS
- Leone D PattersonKLRS
- Brett R HagenKLRS
- Andrew OxtobyKLRS
- Matthew GallKLRS
- Matthew FeinsodKLRS
- Samir Chandrakant PatelKLRS
- Samsara BioCapital GP, LLCKLRS
Questions about ElevateBio, LLC
- How many shares does ElevateBio, LLC own?
- After the latest filing that states it, ElevateBio, LLC directly owned 16,674,766 shares of Allovir, Inc. (KLRS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has ElevateBio, LLC bought or sold stock recently?
- No open-market purchases or sales by ElevateBio, LLC are on file. The filings report grant or award.
- How do I get alerts when ElevateBio, LLC files?
- Follow ElevateBio, LLC on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by ElevateBio, LLC (SEC CIK 0001818060). Totals count each trade once, skipping amendments whose original is on file, from Aug 1, 2022 on. View on SEC EDGAR